Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2025-12-27 @ 5:18 AM
Study NCT ID:
NCT03412292
Status:
UNKNOWN
Last Update Posted:
2022-01-19
First Post:
2018-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)
Sponsor:
Maxinovel Pty., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-01-08
First Submit QC Date:
None
Study First Post Date:
2018-01-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-18
Last Update Post Date:
2022-01-19
Last Update Post Date Type:
ACTUAL